OTCMKTS:PFSCF ProMetic Life Sciences (PFSCF) Stock Price, News & Analysis → A scientific breakthrough in energy technology? (From DTI) (Ad) Free PFSCF Stock Alerts $5.47 0.00 (0.00%) (As of 11/18/2019) Add Compare Share Share Today's Range$5.47▼$5.4750-Day Range$5.47▼$5.4752-Week Range$5.47▼$352.00VolumeN/AAverage Volume279 shsMarket Capitalization$127.45 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get ProMetic Life Sciences alerts: Email Address Ad DTINew way to “hijack” stocksWe may have just found a unique way to “hijack” the stock market… No, it’s not a matter of picking the next Amazon or guessing on the next A.I. moonshot like NVDA… Options expert, Nate Tucci, claims as long as you deploy a certain type of trade before the end of the week anyone could have a shot to target right around $1,250 in a matter of days (based on $2.5k invested) But that’s not even the best part… Unlike most methods, you don’t need to even know WHEN to exit this trade…Click here to catch the next Automated Option About ProMetic Life Sciences Stock (OTCMKTS:PFSCF)Prometic Life Sciences Inc. operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals. The company was founded in 1992 and is based in Laval, Canada.Read More PFSCF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PFSCF Stock News HeadlinesJanuary 29, 2023 | finance.yahoo.comThere's Been No Shortage Of Growth Recently For TMC Life Sciences Berhad's (KLSE:TMCLIFE) Returns On CapitalJanuary 29, 2023 | reuters.comIndia's Glenmark Life Sciences Q3 profit rises 1% on API strengthJune 18, 2024 | Priority Gold (Ad)Biden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...May 10, 2022 | markets.businessinsider.comHere's what to expect from Prometic Life Sciences's earnings reportSee More Headlines Receive PFSCF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ProMetic Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolOTCMKTS:PFSCF Previous SymbolNASDAQ:PFSCF CUSIPN/A CIKN/A Webwww.prometic.com Phone1-450-781-0115FaxN/AEmployees487Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-150,730,000.00 Net Margins-894.02% Pretax MarginN/A Return on Equity-3,350.55% Return on Assets-67.76% Debt Debt-to-Equity RatioN/A Current Ratio0.95 Quick Ratio0.71 Sales & Book Value Annual Sales$36.55 million Price / Sales3.49 Cash FlowN/A Price / Cash FlowN/A Book Value($67.63) per share Price / Book-0.08Miscellaneous Outstanding Shares23,313,000Free FloatN/AMarket Cap$127.45 million OptionableNot Optionable Beta2.46 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Kenneth H. Galbraith (Age 56)CEO & Director Mr. Bruce PritchardCOO & Interim CFOMr. Patrick SartoreChief Legal Officer & Corp. Sec.Mr. Bruce Wendel (Age 65)Chief Bus. Devel. Officer Dr. John Moran (Age 73)Chief Medical Officer Key CompetitorsKalVista PharmaceuticalsNASDAQ:KALVAvid BioservicesNASDAQ:CDMOAnnexonNASDAQ:ANNXAstria TherapeuticsNASDAQ:ATXSMereo BioPharma GroupNASDAQ:MREOView All Competitors PFSCF Stock Analysis - Frequently Asked Questions How have PFSCF shares performed in 2024? ProMetic Life Sciences' stock was trading at $5.4670 on January 1st, 2024. Since then, PFSCF stock has increased by 0.0% and is now trading at $5.4670. View the best growth stocks for 2024 here. How do I buy shares of ProMetic Life Sciences? Shares of PFSCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PFSCF) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredDoes this make you sick?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have...Allegiance Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProMetic Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProMetic Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.